Cigna Group $CI Stock Holdings Increased by Lombard Odier Asset Management Switzerland SA

Lombard Odier Asset Management Switzerland SA raised its position in shares of Cigna Group (NYSE:CI) by 15.3% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20,876 shares of the health services provider’s stock after buying an additional 2,776 shares during the quarter. Lombard Odier Asset Management Switzerland SA’s holdings in Cigna Group were worth $6,901,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Flaharty Asset Management LLC acquired a new stake in shares of Cigna Group during the 1st quarter valued at approximately $28,000. 1248 Management LLC acquired a new position in Cigna Group in the first quarter worth $29,000. Solstein Capital LLC bought a new stake in Cigna Group during the second quarter valued at $29,000. Activest Wealth Management raised its holdings in shares of Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares during the period. Finally, Chilton Capital Management LLC acquired a new stake in shares of Cigna Group during the second quarter worth $30,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CI. Truist Financial dropped their price objective on shares of Cigna Group from $375.00 to $310.00 in a research note on Friday, October 31st. UBS Group set a $294.00 target price on Cigna Group in a report on Wednesday, November 12th. Wells Fargo & Company cut their price target on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft lowered their price objective on Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Finally, Leerink Partners dropped their target price on Cigna Group from $300.00 to $270.00 in a research report on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $334.45.

Insider Buying and Selling at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David Cordani bought 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, with a total value of $999,931.92. Following the purchase, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.70% of the stock is currently owned by company insiders.

Cigna Group Trading Down 0.6%

NYSE:CI opened at $263.75 on Tuesday. The stock has a market cap of $70.45 billion, a price-to-earnings ratio of 11.63, a PEG ratio of 0.96 and a beta of 0.25. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The business has a fifty day moving average of $282.76 and a 200-day moving average of $295.22.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping the consensus estimate of $7.64 by $0.19. The business had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.64%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.